Risk-score based strategy to minimize antibiotic exposure in children with sickle cell disease and fever

Area of Science:

• Pediatrics
• Infectious Diseases
• Hematology

Background:

• Severe bacterial infections (SBI) pose a significant risk for children with sickle cell disease (SCD).
• Current practice often involves empirical broad-spectrum antibiotics and hospitalization for febrile episodes in SCD patients due to SBI risk.
• Reducing unnecessary antibiotic use and hospitalizations is a clinical goal.

Purpose of the Study:

• To develop and validate a predictive risk score for severe bacterial infections (SBI) in febrile children with sickle cell disease (SCD).
• To stratify patients into low, intermediate, and high-risk groups for SBI.
• To provide a tool for safer management decisions, potentially minimizing antibiotic treatments and hospital admissions.

Main Methods:

• Prospective study involving 79 children with SCD presenting with fever.
• Development of a risk score incorporating C-reactive protein (CRP), Interleukin-6 (IL-6), and hypoxemia.
• Validation of the score's predictive performance using Area Under the Curve (AUC) for confirmed and possible SBI.

Main Results:

• The optimal risk score included CRP > 3 mg/dl, IL-6 > 125 pg/ml, and hypoxemia.
• The score demonstrated high predictive accuracy with an AUC of 0.91 for confirmed SBI and 0.86 for possible SBI.
• Patients were successfully classified into low, intermediate, and high-risk categories for SBI.

Conclusions:

• A novel risk score effectively predicts the likelihood of SBI in febrile children with SCD.
• This score can aid clinicians in making informed decisions regarding antibiotic therapy and hospitalization.
• Implementation of this risk-score-based management could lead to a safe reduction in antibiotic exposure and hospital admissions for low-risk SCD patients.